The iCS-digital test now published  in Stem Cell Reports

The iCS-digital TM test now published in Stem Cell Reports

Recurrent Genetic Abnormalities in Human Pluripotent Stem Cells: Definition and Routine Detection in Culture Supernatant by Targeted Droplet Digital PCR

In the article published in Stem Cell Reports in January 2020, Assou et al. demonstrate the interest of the iCS-digital TM test for routine human pluripotent stem cell (hPSC) screening. Thanks to the specificity of the digital PCR (dPCR) probe panel, the simplicity of sample collection, and the accuracy of the ddPCR technology, this test allows the fast and straightforward monitoring of hPSC integrity.

This innovative test can change how hPSC quality controls are implemented for basic research and cell therapy by increasing the test frequency to secure cell productions and avoid expensive and time-consuming cell cultures.

The iCS-digital TM test is exclusively provided by Stem Genomics as a full service.
To request technical information or ask for a quote, please follow this link :

Link to the publication

Discover the test and request a quote

Latest news

discover and share

The discovery and recent advances in the CRISPR/Cas9 gene-editing technology have profoundly reshaped the field of genome engineering and allowed the generation of a wide range of mutant cell lines at an unprecedented rate. However, CRISPR/Cas9 gene editing in hPSCs can also pose a threat to the overall genomic integrity. Why? To know more, have a look at our July newsletter!

Stem cells are the heart of many of tomorrow personalized therapies. Join us at the most comprehensive meeting in stem cell science, the ISSCR 2021. It will take place virtually from 21 to 26 June 2021. Discover our services for your stem cell research projects and meet us at our booth during this virtual event! We are eager to answer any questions you might have.

Stay informed

Subscribe to our newsletter

Subscribe to our newsletter
By subscribing, you authorize Stem Genomics to register your email address. We will only use your email address to send you our newsletter. We respect your data and follow GDPR. Please see our privacy policy for further details.